<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05611502</url>
  </required_header>
  <id_info>
    <org_study_id>21510</org_study_id>
    <secondary_id>R00AA027830</secondary_id>
    <nct_id>NCT05611502</nct_id>
  </id_info>
  <brief_title>Influence of TMS on Attention Modulation</brief_title>
  <acronym>TAM</acronym>
  <official_title>A Combined Neurofeedback- TMS Intervention for Alcohol Use Disorder - Aim 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Auburn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Auburn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to help understand how attention processes influence brain&#xD;
      engagement during emotion and social cognition. The investigators also want to know if these&#xD;
      processes are associated with drinking alcohol.&#xD;
&#xD;
      Participation includes three study visits of about 2 hours each over approximately a month.&#xD;
      The first visit involves a magnetic resonance imaging (MRI) scan and answering survey&#xD;
      questions. Each of the next two visits will involve a session of transcranial magnetic&#xD;
      stimulation (TMS, a non-invasive brain stimulation technique) followed by another MRI scan.&#xD;
&#xD;
      People in the Auburn/Opelika area 19 or older are eligible to participate. People who drink&#xD;
      alcohol and people who do not drink or don't drink very much are invited to participate.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 11, 2022</start_date>
  <completion_date type="Anticipated">August 10, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 10, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Participants will be randomly assigned to receive each arm in counterbalanced order (AB or BA).</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in attention switching</measure>
    <time_frame>Baseline, immediately following TMS A, immediately following TMS B</time_frame>
    <description>MRI Task- analysis of behavioral data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in sociomoral attention switching</measure>
    <time_frame>Baseline, immediately following TMS A, immediately following TMS B</time_frame>
    <description>MRI Task- analysis of behavioral data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in cue reactivity</measure>
    <time_frame>Baseline, immediately following TMS A, immediately following TMS B</time_frame>
    <description>MRI Task- analysis of behavioral data</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in brain activity attention switching</measure>
    <time_frame>Baseline, immediately following TMS A, immediately following TMS B</time_frame>
    <description>MRI Task- analysis of imaging (fMRI) data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in brain activity during sociomoral attention switching</measure>
    <time_frame>Baseline, immediately following TMS A, immediately following TMS B</time_frame>
    <description>MRI Task- analysis of imaging (fMRI) data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in brain activity during cue reactivity</measure>
    <time_frame>Baseline, immediately following TMS A, immediately following TMS B</time_frame>
    <description>MRI Task- analysis of imaging (fMRI) data</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Drinking, Alcohol</condition>
  <arm_group>
    <arm_group_label>TMS A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TMS administered over right frontal eye field at 10 Hz, 110% of MT, 60 x 5 sec trains, 25 sec ITI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TMS B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TMS administered over right frontal eye field at 1 Hz, 110% of MT, 7 x 225 sec trains, 30 sec ITI</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TMS</intervention_name>
    <description>TMS will be administered in a pattern that is either excitatory or inhibitory.</description>
    <arm_group_label>TMS A</arm_group_label>
    <arm_group_label>TMS B</arm_group_label>
    <other_name>Magventure MagPro</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1. Age 19 or Older&#xD;
&#xD;
        2A. (Drinker Group): Reports consuming 4 [if female]/ 5 [if male] or more standard drinks&#xD;
        on one occasion at least 2 times a month AND/OR reports consuming more than 7 [if female]/&#xD;
        14 [if male] standard drinks per week on average&#xD;
&#xD;
        2B. (Healthy Volunteer Group): Reports consuming 4 [if female]/ 5 [if male] or more&#xD;
        standard drinks on one occasion less than once a month AND reports consuming less than 7&#xD;
        [if female]/ 14 [if male] standard drinks per week on average&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. MRI Contraindications&#xD;
&#xD;
               1. Presence of metal in the body that would make having a 7T MRI unsafe (including&#xD;
                  facial tattoos)&#xD;
&#xD;
               2. Claustrophobia, such that individual would be unable to stay in the MRI for up to&#xD;
                  1 hr&#xD;
&#xD;
               3. Hearing loss, including tinnitus, that might be made worse by MRI or TMS&#xD;
&#xD;
          2. TMS Contraindications&#xD;
&#xD;
               1. Has ever had a seizure, or has a family history of epilepsy&#xD;
&#xD;
               2. Taking medications or substances that lower the seizure threshold*&#xD;
&#xD;
               3. Implanted devices that are in the head or rely on physiological signals&#xD;
&#xD;
               4. History of neurological disease, such as stroke or brain tumor&#xD;
&#xD;
               5. Head injury with loss of consciousness greater than 30 minutes&#xD;
&#xD;
               6. Actively withdrawing from alcohol&#xD;
&#xD;
          3. Family history of schizophrenia or presence of psychotic symptoms&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samantha J Fede, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>SCAMPI Lab</last_name>
    <phone>334-521-2807</phone>
    <email>scampi@auburn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Auburn University</name>
      <address>
        <city>Auburn</city>
        <state>Alabama</state>
        <zip>36849</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SCAMPI Lab</last_name>
      <phone>334-521-2807</phone>
      <email>scampi@auburn.edu</email>
    </contact>
    <investigator>
      <last_name>Samantha J Fede, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>October 26, 2022</study_first_submitted>
  <study_first_submitted_qc>November 3, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2022</study_first_posted>
  <last_update_submitted>November 3, 2022</last_update_submitted>
  <last_update_submitted_qc>November 3, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Auburn University</investigator_affiliation>
    <investigator_full_name>Samantha Fede</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>alcohol</keyword>
  <keyword>attention</keyword>
  <keyword>TMS</keyword>
  <keyword>binge drinking</keyword>
  <keyword>emotion</keyword>
  <keyword>social cognition</keyword>
  <keyword>moral</keyword>
  <keyword>MRI</keyword>
  <keyword>frontal eye fields</keyword>
  <keyword>moral cognition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be shared through the NIAAA Data Archive according to standard NIAAA procedures. This will include deidentified behavioral, self-report, and imaging data.&#xD;
Participants will have the option to opt out of having their individual data available.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

